130 related articles for article (PubMed ID: 1535517)
1. Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells.
Eizirik DL; Tracey DE; Bendtzen K; Sandler S
Autoimmunity; 1992; 12(2):127-33. PubMed ID: 1535517
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 beta induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis.
Eizirik DL
Autoimmunity; 1991; 10(2):107-13. PubMed ID: 1782324
[TBL] [Abstract][Full Text] [Related]
3. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
Eizirik DL; Welsh N; Hellerström C
J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
[TBL] [Abstract][Full Text] [Related]
4. Short exposure of rat pancreatic islets to interleukin-1 beta induces a sustained but reversible impairment in beta-cell function: influence of protease activation, gene transcription, and protein synthesis.
Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Mar; 128(3):1611-6. PubMed ID: 1999175
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation.
Sjöholm A
FEBS Lett; 1991 Sep; 289(2):249-52. PubMed ID: 1655527
[TBL] [Abstract][Full Text] [Related]
6. Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium.
Borg LA; Eizirik DL
Immunol Lett; 1990 Dec; 26(3):253-8. PubMed ID: 2086454
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation.
Hughes JH; Colca JR; Easom RA; Turk J; McDaniel ML
J Clin Invest; 1990 Sep; 86(3):856-63. PubMed ID: 2203826
[TBL] [Abstract][Full Text] [Related]
11. Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events.
Eizirik DL; Sandler S
Diabetologia; 1989 Nov; 32(11):769-73. PubMed ID: 2687062
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase.
Welsh N; Eizirik DL; Bendtzen K; Sandler S
Endocrinology; 1991 Dec; 129(6):3167-73. PubMed ID: 1720090
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F
Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
15. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.
Zumsteg U; Reimers JI; Pociot F; Mørch L; Helqvist S; Brendel M; Alejandro R; Mandrup-Poulsen T; Dinarello CA; Nerup J
Diabetologia; 1993 Aug; 36(8):759-66. PubMed ID: 8405744
[TBL] [Abstract][Full Text] [Related]
16. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
Kawahara DJ; Kenney JS
Cytokine; 1991 Mar; 3(2):117-24. PubMed ID: 1888882
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
Comens PG; Wolf BA; Unanue ER; Lacy PE; McDaniel ML
Diabetes; 1987 Aug; 36(8):963-70. PubMed ID: 3297891
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta increases the activity of superoxide dismutase in rat pancreatic islets.
Borg LA; Cagliero E; Sandler S; Welsh N; Eizirik DL
Endocrinology; 1992 May; 130(5):2851-7. PubMed ID: 1533363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
